Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin

Journal of the National Cancer Institute

Volumn 89, Issue 11, 1997, Pages 817-818

  Kris, M G ^a   Radford, J E ^a   Pizzo, B A ^a   Inabinet, R ^a   Hesketh, A ^a   Hesketh, P J ^a  

^a Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; ANTINEOPLASTIC AGENT; CISPLATIN; UNCLASSIFIED DRUG; ANTIEMETIC AGENT; NEUROKININ 1 RECEPTOR; PIPERIDINE DERIVATIVE;

CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG RECEPTOR BINDING; HUMAN; LETTER; VOMITING; ADULT; AGED; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ANTAGONISM; FEMALE; MALE; MIDDLE AGED;

ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; RECEPTORS, NEUROKININ-1; VOMITING;

EID: 0030609853     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.11.817     Document Type: Letter

References (12)